Join us to hear exciting news on the collaboration between MDIC, NIST and Revvity using Genome in a Bottle Consortium (GIAB) cell lines to develop highly characterised somatic reference standards. Based on engineered cell lines containing disease-relevant cancer variants and supported by expertly curated datasets, these standards are set to simplify the verification and monitoring of NGS-based cancer assays and help improve the accuracy of results. Don't miss this opportunity to stay ahead of the curve in precision oncology.
